The fast-moving nature of biotechnology innovation means architects and designers for Regeneron have to plan for researchers’ requirements to change by the time new laboratories open on the Tarrytown, N.Y., campus. The campus is undergoing a $1.8 billion expansion, adding 900,000 sf of new laboratory and office space, along with additional parking, amenities, and infrastructure to support research and development.
MilliporeSigma, a subsidiary of Merck KGaA, opened a $317.2 million facility in Rockville in October of 2024. Located in the Alexandria Center at Traville Gateway, the 260,000-sf building provides advanced laboratories for biosafety testing, analytical development, viral clearance, and cell bank manufacturing. The project represents the company's largest investment to date in contract testing operations.
Scripps Research Institute opened the Chi-Huey Wong Laboratories for Biomedical Research in August of 2024. Creating a new gateway to the La Jolla campus, the 83,000-sf structure provides leading-edge environments for drug discovery and development. DGA was the architect for the collaborative facility, which features interconnected open laboratories and a double-height lobby.
The decreasing amount of time researchers spend in their labs is changing research facility design and space allocation, with an increased need for lab support space, a more significant reliance on core facilities, the creation of additional write-up and data analysis environments, and the purposeful inclusion of collaboration spaces.
Eli Lilly and Company opened the $700 million Lilly Seaport Innovation Center (LSC) in Boston in August of 2024. Developed by Alexandria Real Estate Equities and National Development, the 346,000-rsf facility offers Class A research environments for biomedical discovery. The 12-story structure also houses the first Lilly Gateway Labs on the East Coast to enable biotech start-ups to collaborate with Lilly scientists.
